CASSAVA SCIENCES INC (SAVA) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2025-11-25

CASSAVA SCIENCES INC (SAVA) — no SEC Form 4 insider filings recorded in the last 90 days. 3 Form 8-K material event filings were reported by SAVA in the last 90 days. InsiderAlpha tracks every SAVA SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About CASSAVA SCIENCES INC (SAVA)

SIC classification	Pharmaceutical Preparations (SIC 2834)
SEC CIK	0001069530

90-Day SEC Filing Activity

Form 8-K filings (90d)	3
Latest Form 4 filing	2025-11-25

Recent SAVA Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2025-09-30	Cook Robert Christopher	Chief Operating Legal Office	P — Open-market purchase	13.7K	$2.91	$40K	SEC
2025-09-22	Barry Richard	President CEO	P — Open-market purchase	7.2K	$2.28	$16K	SEC
2025-09-19	Barry Richard	President CEO	P — Open-market purchase	46.9K	$2.29	$107K	SEC
2025-09-19	Barry Richard	President CEO	P — Open-market purchase	400	$2.25	$900	SEC
2025-09-18	Barry Richard	President CEO	P — Open-market purchase	5.4K	$2.13	$12K	SEC
2025-09-18	Barry Richard	President CEO	P — Open-market purchase	185.2K	$2.24	$415K	SEC
2024-11-29	Kupiec James William	Chief Medical Officer	S — Open-market sale	4.0K	$3.87	$15K	SEC
2024-11-29	Schoen Eric	Chief Financial Officer	M — Option exercise	50.0K	$1.18	$59K	SEC
2024-11-29	Schoen Eric	Chief Financial Officer	S — Open-market sale	2.0K	$3.82	$8K	SEC
2024-11-29	Schoen Eric	Chief Financial Officer	S — Open-market sale	59.8K	$3.86	$231K	SEC

All transactions sourced from SEC EDGAR Form 4 filings for CASSAVA SCIENCES INC (SAVA). Updated in real time as new filings are submitted to the SEC.

Recent SAVA Form 8-K Material Events

2026-06-15 — Item 5.02, 5.07, 9.01 [SEC]
2026-05-07 — Item 2.02, 9.01 [SEC]
2026-04-28 — Item 5.02 [SEC]
2026-03-12 — Item 2.02, 9.01 · Earnings · neutral [SEC]
Filana Therapeutics (formerly Cassava Sciences) issued a press release on March 12, 2026 reporting results of operations and financial condition. The 8-K filing itself contains no specific financial data, beat/miss language, or guidance changes—only a reference to the attached pr
2026-03-10 — Item 5.03, 7.01, 9.01 · Other · neutral [SEC]
Cassava Sciences, Inc. changed its legal name to Filana Therapeutics, Inc., effective March 10, 2026. The company's common stock will trade under the new ticker symbol 'FLNA' on Nasdaq starting March 11, 2026. The company also adopted amended and restated bylaws to modernize gove

Recent Insider Filings

2025-11-25 — Anderson Robert Eugene Jr (Director)
2025-11-24 — Barry Richard (President & CEO)
2025-11-20 — Barry Richard (President & CEO)
2025-10-22 — Bir Dawn Carter (Director)
2025-09-30 — Cook Robert Christopher (Chief Operating Legal Office)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in SAVA insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

SAVA Insider Trading — FAQ

What is the latest insider trade for SAVA?: CASSAVA SCIENCES INC (SAVA) had 0 insider filings in the last 90 days, with the most recent on 2025-11-25. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying SAVA stock?: 0 insider purchases of SAVA were filed in the last 90 days.
How many insiders are selling SAVA stock?: 0 insider sales of SAVA were filed in the last 90 days.
Where can I see SAVA SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every SAVA SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Related Companies — Recent Insider Activity

Learn More

Open the live SAVA dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.